The critical role of ECM proteins within the human MSC niche in endothelial differentiation

Biomaterials

Volumn 34, Issue 17, 2013, Pages 4223-4234

  Wang, Chih Hsiang ^a,b,c   Wang, Ting Ming ^c   Young, Tai Horng ^d   Lai, Yiu Kay ^a   Yen, Men Luh ^b,c,d  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Bone; Endothelial differentiation; Extracellular matrix; FOXC2; Integrin v 3 CD61; Mesenchymal stem cells

Indexed keywords

ENDOTHELIAL DIFFERENTIATION; EXTRACELLULAR MATRICES; FOXC2; INTEGRINS; MESENCHYMAL STEM CELL;

BLOOD VESSELS; BONE; ENDOTHELIAL CELLS; FLOWCHARTING; OSTEOBLASTS; STEM CELLS; TISSUE; TRANSCRIPTION FACTORS;

CELL CULTURE;

ALPHA INTEGRIN; BETA3 INTEGRIN; CELL SURFACE MARKER; LAMININ; LOW DENSITY LIPOPROTEIN; SCLEROPROTEIN; TRANSCRIPTION FACTOR FOXC2;

ADIPOCYTE; ANGIOGENESIS; ARTICLE; BONE MARROW CELL; BONE TISSUE; CARTILAGE CELL; CELL CULTURE; CELL DIFFERENTIATION; CHICK; CHORIOALLANTOIS; DOWNSTREAM PROCESSING; ENDOTHELIUM CELL; FETUS CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; MESENCHYMAL STEM CELL; OSTEOBLAST; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; STEM CELL NICHE; TRABECULAR BONE; UPREGULATION;

ADULT; ADULT STEM CELLS; ANIMALS; BIOLOGICAL MARKERS; BONE MARROW CELLS; CELL DIFFERENTIATION; CHICK EMBRYO; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FETUS; FORKHEAD TRANSCRIPTION FACTORS; GENE KNOCKDOWN TECHNIQUES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LAMININ; MESENCHYMAL STROMAL CELLS; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOBLASTS; STEM CELL NICHE; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 84875530723     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.02.062     Document Type: Article

References (51)

1. Kanczler J.M., Oreffo R.O. Osteogenesis and angiogenesis: the potential for engineering bone. Eur Cell Mater 2008, 15:100-114.
2. Gerber H.P., Ferrara N. Angiogenesis and bone growth. Trends Cardiovas Med 2000, 10:223-228.
3. Carano R.A., Filvaroff E.H. Angiogenesis and bone repair. Drug Discov Today 2003, 8:980-989.
4. Kronenberg H.M. Developmental regulation of the growth plate. Nature 2003, 423:332-336.
5. Rouwkema J., Rivron N.C., van Blitterswijk C.A. Vascularization in tissue engineering. Trends Biotechnol 2008, 26:434-441.
6. Santos M.I., Reis R.L. Vascularization in bone tissue engineering: physiology, current strategies, major hurdles and future challenges. Macromol Biosci 2010, 10:12-27.
7. Ducy P., Zhang R., Geoffroy V., Ridall A.L., Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997, 89:747-754.
8. Marie P.J. Transcription factors controlling osteoblastogenesis. Arch Biochem Biophys 2008, 473:98-105.
9. Owen M., Friedenstein A.J. Stromal stem cells: marrow-derived osteogenic precursors. Ciba Found Symp 1988, 136:42-60.
10. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
11. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997, 276:71-74.
12. Noth U., Osyczka A.M., Tuli R., Hickok N.J., Danielson K.G., Tuan R.S. Multilineage mesenchymal differentiation potential of human trabecular bone-derived cells. J Orthop Res 2002, 20:1060-1069.
13. Sakaguchi Y., Sekiya I., Yagishita K., Ichinose S., Shinomiya K., Muneta T. Suspended cells from trabecular bone by collagenase digestion become virtually identical to mesenchymal stem cells obtained from marrow aspirates. Blood 2004, 104:2728-2735.
14. Yen M.L., Chien C.C., Chiu I.M., Huang H.I., Chen Y.C., Hu H.I., et al. Multilineage differentiation and characterization of the human fetal osteoblastic 1.19 cell line: a possible in vitro model of human mesenchymal progenitors. Stem Cells 2007, 25:125-131.
15. Orkin S.H., Zon L.I. Hematopoiesis: an evolving paradigm for stem cell biology. Cell 2008, 132:631-644.
16. Grellier M., Bordenave L., Amedee J. Cell-to-cell communication between osteogenic and endothelial lineages: implications for tissue engineering. Trends Biotechnol 2009, 27:562-571.
17. Grellier M., Ferreira-Tojais N., Bourget C., Bareille R., Guillemot F., Amedee J. Role of vascular endothelial growth factor in the communication between human osteoprogenitors and endothelial cells. J Cell Biochem 2009, 106:390-398.
18. Guillotin B., Bareille R., Bourget C., Bordenave L., Amedee J. Interaction between human umbilical vein endothelial cells and human osteoprogenitors triggers pleiotropic effect that may support osteoblastic function. Bone 2008, 42:1080-1091.
19. Villars F., Guillotin B., Amedee T., Dutoya S., Bordenave L., Bareille R., et al. Effect of HUVEC on human osteoprogenitor cell differentiation needs heterotypic gap junction communication. Am J Physiol Cell Physiol 2002, 282:C775-C785.
20. Unger R.E., Sartoris A., Peters K., Motta A., Migliaresi C., Kunkel M., et al. Tissue-like self-assembly in cocultures of endothelial cells and osteoblasts and the formation of microcapillary-like structures on three-dimensional porous biomaterials. Biomaterials 2007, 28:3965-3976.
21. Rouwkema J., de Boer J., Van Blitterswijk C.A. Endothelial cells assemble into a 3-dimensional prevascular network in a bone tissue engineering construct. Tissue Eng 2006, 12:2685-2693.
22. Shalaby F., Ho J., Stanford W.L., Fischer K.D., Schuh A.C., Schwartz L., et al. A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis. Cell 1997, 89:981-990.
23. Oswald J., Boxberger S., Jorgensen B., Feldmann S., Ehninger G., Bornhauser M., et al. Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 2004, 22:377-384.
24. Wang H., Riha G.M., Yan S., Li M., Chai H., Yang H., et al. Shear stress induces endothelial differentiation from a murine embryonic mesenchymal progenitor cell line. Arterioscler Throm Vasc Biol 2005, 25:1817-1823.
25. Janeczek Portalska K., Leferink A., Groen N., Fernandes H., Moroni L., van Blitterswijk C., et al. Endothelial differentiation of mesenchymal stromal cells. PloS One 2012, 7:e46842.
26. Oskowitz A., McFerrin H., Gutschow M., Carter M.L., Pochampally R. Serum-deprived human multipotent mesenchymal stromal cells (MSCs) are highly angiogenic. Stem Cell Res 2011, 6:215-225.
27. Chang C.J., Yen M.L., Chen Y.C., Chien C.C., Huang H.I., Bai C.H., et al. Placenta-derived multipotent cells exhibit immunosuppressive properties that are enhanced in the presence of interferon-gamma. Stem Cells 2006, 24:2466-2477.
28. Wu C.C., Chao Y.C., Chen C.N., Chien S., Chen Y.C., Chien C.C., et al. Synergism of biochemical and mechanical stimuli in the differentiation of human placenta-derived multipotent cells into endothelial cells. J Biomech 2008, 41:813-821.
29. Su J.L., Chiou J., Tang C.H., Zhao M., Tsai C.H., Chen P.S., et al. CYR61 regulates BMP-2-dependent osteoblast differentiation through the {alpha}v{beta}3 integrin/integrin-linked kinase/ERK pathway. J Biol Chem 2010, 285:31325-31336.
30. Auerbach R., Lewis R., Shinners B., Kubai L., Akhtar N. Angiogenesis assays: a critical overview. Clin Chem 2003, 49:32-40.
31. Tseng P.C., Young T.H., Wang T.M., Peng H.W., Hou S.M., Yen M.L. Spontaneous osteogenesis of MSCs cultured on 3D microcarriers through alteration of cytoskeletal tension. Biomaterials 2012, 33:556-564.
32. De Luca A., Gallo M., Aldinucci D., Ribatti D., Lamura L., D'Alessio A., et al. Role of the EGFR ligand/receptor system in the secretion of angiogenic factors in mesenchymal stem cells. J Cell Physiol 2011, 226:2131-2138.
33. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8:315-317.
34. De Val S., Black B.L. Transcriptional control of endothelial cell development. Dev Cell 2009, 16:180-195.
35. De Val S., Chi N.C., Meadows S.M., Minovitsky S., Anderson J.P., Harris I.S., et al. Combinatorial regulation of endothelial gene expression by ets and forkhead transcription factors. Cell 2008, 135:1053-1064.
36. Hayashi H., Sano H., Seo S., Kume T. The Foxc2 transcription factor regulates angiogenesis via induction of integrin beta3 expression. J Biol Chem 2008, 283:23791-23800.
37. Kleinman H.K., McGarvey M.L., Liotta L.A., Robey P.G., Tryggvason K., Martin G.R. Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. Biochemistry 1982, 21:6188-6193.
38. Kopen G.C., Prockop D.J., Phinney D.G. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci U S A 1999, 96:10711-10716.
39. Ducy P., Schinke T., Karsenty G. The osteoblast: a sophisticated fibroblast under central surveillance. Science 2000, 289:1501-1504.
40. Wright E., Hargrave M.R., Christiansen J., Cooper L., Kun J., Evans T., et al. The Sry-related gene Sox9 is expressed during chondrogenesis in mouse embryos. Nat Genet 1995, 9:15-20.
41. Takada I., Suzawa M., Matsumoto K., Kato S. Suppression of PPAR transactivation switches cell fate of bone marrow stem cells from adipocytes into osteoblasts. Ann N Y Acad Sci 2007, 1116:182-195.
42. Ferdous A., Caprioli A., Iacovino M., Martin C.M., Morris J., Richardson J.A., et al. Nkx2-5 transactivates the Ets-related protein 71 gene and specifies an endothelial/endocardial fate in the developing embryo. Proc Natl Acad Sci U S A 2009, 106:814-819.
43. Kume T., Jiang H., Topczewska J.M., Hogan B.L. The murine winged helix transcription factors, Foxc1 and Foxc2, are both required for cardiovascular development and somitogenesis. Genes Dev 2001, 15:2470-2482.
44. Davis G.E., Senger D.R. Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization. Circ Res 2005, 97:1093-1107.
45. Mahabeleshwar G.H., Feng W., Phillips D.R., Byzova T.V. Integrin signaling is critical for pathological angiogenesis. J Exp Med 2006, 203:2495-2507.
46. Bader B.L., Rayburn H., Crowley D., Hynes R.O. Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all alpha v integrins. Cell 1998, 95:507-519.
47. Brooks P.C., Clark R.A., Cheresh D.A. Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 1994, 264:569-571.
48. Soldi R., Mitola S., Strasly M., Defilippi P., Tarone G., Bussolino F. Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2. EMBO J 1999, 18:882-892.
49. Schneller M., Vuori K., Ruoslahti E. Alphavbeta3 integrin associates with activated insulin and PDGFbeta receptors and potentiates the biological activity of PDGF. EMBO J 1997, 16:5600-5607.
50. Gonzalez A.M., Gonzales M., Herron G.S., Nagavarapu U., Hopkinson S.B., Tsuruta D., et al. Complex interactions between the laminin alpha 4 subunit and integrins regulate endothelial cell behavior in vitro and angiogenesis in vivo. Proc Natl Acad Sci U S A 2002, 99:16075-16080.
51. Estrach S., Cailleteau L., Franco C.A., Gerhardt H., Stefani C., Lemichez E., et al. Laminin-binding integrins induce Dll4 expression and Notch signaling in endothelial cells. Circ Res 2011, 109:172-182.